Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Heart

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/heart.85.4.424PMID 11250970PMCID PMC1729704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Importance of Atrial Flutter Isthmus in Postoperative Intra-Atrial Reentrant Tachycardia

  2000cited by this paper
• Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.

  1999cited by this paper
• Isoproterenol to evaluate resumption of conduction after right atrial isthmus ablation in type I atrial flutter.

  1999cited by this paper
• Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.

  1999cited by this paper
• Mechanism of Antiarrhythmic Effects of Class Ic Drugs in Paroxysmal Atrial Fibrillation in Man

  1998cited by this paper
• New electrocardiographic criteria for the differentiation between counterclockwise and clockwise atrial flutter: correlation with electrophysiological study and radiofrequency catheter ablation

  1998cited by this paper
• The Architecture of the Atrial Musculature Between the Orifice of the Inferior Caval Vein and the Tricuspid Valve: The Anatomy of the Isthmus

  1998cited by this paper
• Hybrid Pharmacologic and Ablative Therapy: A Novel and Effective Approach for the Management of Atrial Fibrillation

  1998cited by this paper
• A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

  1997cited by this paper
• Radiofrequency catheter ablation of atrial flutter. Further insights into the various types of isthmus block: application to ablation during sinus rhythm.

  1996cited by this paper
• High-density mapping of electrically induced atrial fibrillation in humans.

  1994cited by this paper
• Role of anisotropy in determining the selective action of antiarrhythmics in atrial flutter in the dog.

  1992cited by this paper
• Atrial activation sequence during atrial flutter in the canine pericarditis model and its effects on the polarity of the flutter wave in the electrocardiogram.

  1991cited by this paper

• Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

  2025cites this paper
• JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia

  2024cites this paper
• Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect.

  2024cites this paper
• 2023 Cardiac Society of Australia and New Zealand Expert Position Statement on Catheter and Surgical Ablation for Atrial Fibrillation.

  2024cites this paper
• Cavotricuspid Isthmus-Dependent Atrial Flutter. Beyond Simple Linear Ablation

  2024cites this paper
• JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.

  2023cites this paper
• Long-term results of two-stage ablation approach in coexistent atrial fibrillation and typical atrial flutter: prospective randomized study

  2023cites this paper
• Drug-Induced Atrial Fibrillation / Atrial Flutter

  2022cites this paper
• Electrolyte’s imbalance role in atrial fibrillation: Pharmacological management

  2022cites this paper
• Guía ESC 2020 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración de la European Association of Cardio-Thoracic Surgery (EACTS)

  2021cites this paper
• Current Evidence on Prevention of Atrial Fibrillation: Modifiable Risk Factors and the Effects of Risk Factor Intervention

  2021cites this paper
• Localized Atrial Tachycardia and Dispersion Regions in Atrial Fibrillation: Evidence of Spatial Concordance

  2021cites this paper
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

  2020cites this paper
• 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).

  2019cites this paper
• Revisiting an Underrecognized Strategy for Rhythm Management: Hybrid Therapy for Patients who Convert from Atrial Fibrillation to Flutter on Antiarrhythmic Drugs

  2019cites this paper
• The clinical outcomes of patients who developed typical atrial flutter on class 1C anti arrhythmic medications treated with hybrid approach

  2019cites this paper
• Dynamics of propagation patterns and anti-arrhythmic mechanisms during atrial fibrillation

  2019cites this paper
• Time‐dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses

  2018cites this paper
• Atrial fibrillation and atrial flutter: Two sides of the same coin!

  2017cites this paper
• linical Significance of Inducible trial Flutter During Pulmonary Vein solation in Patients With Atrial Fibrillation

  2016cites this paper
• Colchicine modulates calcium homeostasis and electrical property of HL‐1 cells

  2016cites this paper
• Amiodarone and Risk of Death in Contemporary Patients with Atrial Fibrillation: Findings from the TREAT-AF Study

  2016cites this paper
• Cardiac Radiosurgery for the Treatment of Atrial Fibrillation

  2016cites this paper
• RETRACTED ARTICLE: Long-term mortality prediction of CHA2DS2VASc and HATCH scores in a cohort of patients with typical atrial flutter

  2016cites this paper
• Antiarrhythmic Drug Therapy for Atrial Fibrillation.

  2016cites this paper
• Changes in Diet Quality Scores and Risk of Cardiovascular Disease Among US Men and Women

  2015cites this paper
• Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.

  2015cites this paper
• The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy

  2015cites this paper
• Potassium Channel Blockade Enhances Atrial Fibrillation–Selective Antiarrhythmic Effects of Optimized State-Dependent Sodium Channel Blockade

  2015cites this paper
• Antiarrhythmic drug therapy for atrial fibrillation.

  2014cites this paper
• Failure of hybrid therapy for the prevention of long-term recurrence of atrial fibrillation.

  2014cites this paper
• Drug-Induced Atrial Fibrillation

  2012cites this paper
• Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation

  2012cites this paper
• Atrial Fibrillation Antiarrhythmic Drug Therapy for Atrial Fibrillation

  2012cites this paper
• Atrial fibrillation and atrial flutter: medical management.

  2012cites this paper
• Antiarrhythmic drug therapy for atrial fibrillation.

  2012cites this paper
• Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.

  2012cites this paper
• 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion.

  2012cites this paper
• The value of catheter-based cryoablation for the management of cardiac arrhythmias

  2012cites this paper
• Effektivität und Sicherheit der Katheterablation bei Vorhof- flimmern: Ergebnisse des prospektiven, multizentrischen Vorhofflimmerablationsregisters

  2012cites this paper
• 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion.

  2012cites this paper
• ST-segment elevation in a patient receiving flecainide.

  2011cites this paper
• The Effects of a Bidirectional Cavo-Tricuspid Isthmus Block in Persistent Atrial Fibrillation

  2011cites this paper
• Novel pharmacological targets for the rhythm control management of atrial fibrillation.

  2011cites this paper
• Atypical response of class IC atrial flutter to adenosine.

  2011cites this paper
• Atrial-selective sodium channel block for the treatment of atrial fibrillation

  2009cites this paper
• Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis

  2009cites this paper
• Atrial-selectivesodiumchannel blockforthetreatmentofatrial fibrillation

  2009cites this paper
• The place of hybrid therapies with drugs to supplement nonpharmacological therapies in atrial fibrillation.

  2008cites this paper
• Typical Flutter Ablation as an Adjunct to Catheter Ablation of Atrial Fibrillation.

  2008cites this paper
• Ablation Strategies for Left Atrial Flutter

  2008cites this paper
• Ocena skuteczności ablacji cieśni prawego przedsionka w terapii skojarzonej napadowego migotania przedsionków

  2006cites this paper
• Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms.

  2006cites this paper
• Catheter Ablation of Typical Atrial Flutter. What Are the Long-Term Results and Predictors of Recurrences?

  2006cites this paper
• Cardiac Arrhythmias 2005

  2006cites this paper
• Vorhofflimmern und Vorhofflattern - konservative vs. interventionelle Therapie

  2005cites this paper
• Lessons from catheter ablation: how a proarrhythmic effect has become a therapeutic chance. The case of class IC/III drugs in atrial flutter.

  2005cites this paper
• [Atrial fibrillation -- interventional therapy with respect to age].

  2005cites this paper
• Pharmacological and ablative hybrid therapy of atrial fibrillation

  2005influential citation
• Vorhofflimmern - Interventionelle Differentialtherapie unter besonderer Berücksichtigung des Lebensalters

  2005cites this paper
• Outcome after cavo-tricuspid isthmus ablation in patients with recurrent atrial fibrillation and drug-related typical atrial flutter.

  2004cites this paper
• 研究会 第1回不整脈薬物治療フォーラム 心房細動のhybrid治療におけるI群抗不整脈薬とベプリジルの有用性の比較検討

  2004cites this paper
• Atrial Flutter Induced by Class IC Drugs/Amiodarone: What Are the Long-term Results of Cavo-tricuspidal Isthmus Ablation?

  2004cites this paper
• Clinical significance of inducible atrial flutter during pulmonary vein isolation in patients with atrial fibrillation.

  2004cites this paper
• Late recurrent arrhythmias after ablation of atrial fibrillation: incidence, mechanisms, and treatment.

  2004cites this paper
• Drugs and Ablation in Patients with Atrial Fibrillation and Heart Failure

  2003cites this paper
• Randomized Study Comparing Combined Pulmonary Vein–Left Atrial Junction Disconnection and Cavotricuspid Isthmus Ablation Versus Pulmonary Vein–Left Atrial Junction Disconnection Alone in Patients Presenting With Typical Atrial Flutter and Atrial Fibrillation

  2003cites this paper
• Katheterablation von Antiarrhythmika-induziertem Vorhofflattern bei Patienten mit rekurrierendem Vorhofflimmern

  2003cites this paper
• Global Right Atrial Mapping Delineates Double Posterior Lines of Block in Patients with Typical Atrial Flutter:

  2003cites this paper
• Hybrid therapy for atrial fibrillation

  2003cites this paper
• Class IC/Amiodarone Atrial Flutter: What Are the Long-Term Results of Radiofrequency Ablation?

  2002cites this paper
• Incidence of atrial flutter during treatment of atrial fibrillation by class I antiarrhythmic drugs

  2002cites this paper